US Patent 7618996 Diaryl ether derivatives and uses thereof
Patent 7618996 was granted and assigned to Pfizer Limited on November, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+256 characters)
Article
Patent abstract
Compounds of Formula (I) that act as antagonists at the mu, kappa and/or delta opioid receptors and therefore useful in the treatment of diseases, conditions and/or disorders that benefit from such antagonism in animals are described herein.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07618996 Diaryl ether derivatives and uses thereof US Patent 7618996 Diaryl ether derivatives and uses thereof
Infobox
Patent Number
0761899600
Patent Number
761899600
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
076189960
Date of Patent
November 17, 2009
0Patent Application Number
118523580
Date Filed
September 10, 2007
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
076189960
Date of Patent
November 17, 2009
0Patent Application Number
118523580
Date Filed
September 10, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07618996 Diaryl ether derivatives and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07618996
Date of patent
November 17, 2009
Patent application number
11852358
Date Filed
September 10, 2007
Patent primary examiner
Find more entities like US Patent 7618996 Diaryl ether derivatives and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
